Tuesday, October 1, 2013

Epoprosenol for Injection Now Available in Canada

This month, CARIPUL® (epoprostenol) for Injection became available in Canada by Actelion Pharmaceuticals Canada Inc. for the treatment of idiopathic pulmonary arterial hypertension (IPAH) and pulmonary hypertension secondary to scleroderma spectrum of diseases in NYHA functional Class III and IV patients who have not responded adequately to conventional therapy.

Read article | Read about treatments available in the U.S.

No comments: